These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3100849)

  • 1. Effects of a new anti-inflammatory imidazole derivative, fenflumizole, on platelet aggregation in the rabbit.
    Aono J; Nabata H; Sakai K
    Jpn J Pharmacol; 1986 Dec; 42(4):575-8. PubMed ID: 3100849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenflumizole: interactions with the arachidonic acid cascade.
    Corell T; Hasselmann G; Splawinski J; Wojtaszek B
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):297-303. PubMed ID: 6417973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effects of fenflumizole, a new anti-inflammatory drug, in dogs.
    Nabata H; Uchino M; Okazaki A; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):97-100. PubMed ID: 3626187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fenflumizole on platelet aggregation in man.
    Grande P; Wadt J; Corell T
    Eur J Clin Pharmacol; 1984; 27(2):169-72. PubMed ID: 6437841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic and ulcerogenic effects of fenflumizole, a new anti-inflammatory imidazole derivative, in rats.
    Nabata H; Uchino M; Okazaki A; Yamazaki T; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):93-6. PubMed ID: 3114525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.
    Vinge E; Corell T; Andersson KE
    Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated oral doses of fenflumizole on platelet aggregation and thromboxane formation in man ex vivo.
    Dahl-Puustinen ML; Corell T; Koch K; Puustinen T
    Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):101-6. PubMed ID: 3357910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.
    Grauholt AM; Grande P; Wadt J
    Eur J Clin Pharmacol; 1987; 31(5):547-51. PubMed ID: 2951260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition by fenflumizole tissue cyclooxygenase in rabbits ex vivo.
    Basista M; Grodzińska L; Gryglewski RJ
    Pol J Pharmacol Pharm; 1985; 37(1):41-6. PubMed ID: 3929239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
    Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benzydamine and other non-steroidal anti-inflammatory drugs on platelet aggregation induced by: arachidonic acid, ADP and collagen.
    Catanese B; Picollo R; Corradino C
    Boll Chim Farm; 1986 Jul; 125(7):228-33. PubMed ID: 3099811
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141) on rabbit platelet aggregation in vitro and rat platelet retention.
    Umetsu T; Kato T
    Thromb Haemost; 1978 Feb; 39(1):167-76. PubMed ID: 580491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Momo K; Someya K; Tachiiri T; Mitsuoka Y; Nakamura K; Imai S; Ino T; Ohkubo H
    Arzneimittelforschung; 1992 Jan; 42(1):32-9. PubMed ID: 1586377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arachidonate-induced human platelet aggregation by a single low oral dose of aspirin in combination with a thromboxane synthase inhibitor.
    Cerletti C; Rajtar G; Bertelé V; de Gaetano G
    Thromb Haemost; 1984 Oct; 52(2):215. PubMed ID: 6441306
    [No Abstract]   [Full Text] [Related]  

  • 16. Trifenagrel: a chemically novel platelet aggregation inhibitor.
    Abrahams SL; Hazen RJ; Batson AG; Phillips AP
    J Pharmacol Exp Ther; 1989 May; 249(2):359-65. PubMed ID: 2542526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of intravascular platelet aggregation by continuous platelet counting.
    Smith GM; Duncan GG
    Thromb Res; 1981 Aug; 23(3):275-88. PubMed ID: 6795759
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug (4). Mode of action on anti-inflammatory activity.
    Ono N; Yamasaki Y; Yamamoto N; Sunami A; Miyake H
    Jpn J Pharmacol; 1986 Nov; 42(3):431-9. PubMed ID: 3102823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics and toxicology of fenflumizole, a new non-steroidal anti-inflammatory imidazole derivative.
    Corell T; Hasselmann G
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):288-96. PubMed ID: 6650179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of copper-aspirin complex on platelet aggregation and thrombosis in rabbits and mice.
    Shen ZQ; Liang Y; Chen ZH; Liu WP; Duan L
    J Pharm Pharmacol; 1998 Nov; 50(11):1275-9. PubMed ID: 9877314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.